According to new research, gliomas—a deadly group of brain tumors that are difficult to treat—have increased folate receptor expression, meaning they also show increased uptake of folate-based radiopharmaceuticals on PET imaging.

Clinicians only want the information they need to make treatment decisions, rather than advice on what actions they should take, the survey found. 

SNMMI and ACR are pushing the agency to make modifications retroactive, so specialists can still claim lost revenues impacted by the error. 

The recent CMS coverage determination did not make any mention of beta-amyloid PET imaging that is necessary for both diagnosing Alzheimer’s and monitoring the effectiveness of related treatments.

Precision DL was engineered using a deep neural network, trained with thousands of images, the Chicago-based company said May 30. 

A Medicare Administrative Contractor is wrongly rejecting coverage of PET imaging in cases of infection/inflammation, SNMMI reported recently. 

Blue Earth Diagnostics said this is the first and only PSMA-targeted imaging agent developed with its proprietary radiohybrid technology.

“To achieve organizational objectives in an ever-evolving landscape, imaging providers must develop strategies to meet increased demand for services,” Vizient experts advised.